Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Negri

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Pathology|February 14, 2006
PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcomaM S Lagonigro, E Tamborini, T Negri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2012
Sunitinib malate in solitary fibrous tumor (SFT)S Stacchiotti, T Negri, M Libertini, et al.
Oncogene|June 6, 2006
Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patientsE Tamborini, S Pricl, T Negri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2013
Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenicsS Stacchiotti, M Tortoreto, F Bozzi, et al.
British Journal of Cancer|August 8, 2014
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapyM Tazzari, T Negri, F Rini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2011
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patientsL Licitra, F Perrone, E Tamborini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2013
Phase II study on lapatinib in advanced EGFR-positive chordomaS Stacchiotti, E Tamborini, S Lo Vullo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2014
Activity of sunitinib in extraskeletal myxoid chondrosarcomaS Stacchiotti, M A Pantaleo, A Astolfi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2014
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumourS Stacchiotti, M Tortoreto, G G Baldi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2017
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumourS Stacchiotti, M Saponara, R Frapolli, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Pathology|February 14, 2006
PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcomaM S Lagonigro, E Tamborini, T Negri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2012
Sunitinib malate in solitary fibrous tumor (SFT)S Stacchiotti, T Negri, M Libertini, et al.
Oncogene|June 6, 2006
Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patientsE Tamborini, S Pricl, T Negri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2013
Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenicsS Stacchiotti, M Tortoreto, F Bozzi, et al.
British Journal of Cancer|August 8, 2014
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapyM Tazzari, T Negri, F Rini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2011
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patientsL Licitra, F Perrone, E Tamborini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2013
Phase II study on lapatinib in advanced EGFR-positive chordomaS Stacchiotti, E Tamborini, S Lo Vullo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2014
Activity of sunitinib in extraskeletal myxoid chondrosarcomaS Stacchiotti, M A Pantaleo, A Astolfi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2014
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumourS Stacchiotti, M Tortoreto, G G Baldi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2017
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumourS Stacchiotti, M Saponara, R Frapolli, et al.
Pageof 2